Roche wins as UK hikes pandemic flu drug stocks:FT

Thu Nov 22, 2007 8:44am GMT
 
Email | Print | | Single Page
[-] Text [+]

LONDON (Reuters) - Sales of Roche Holdings AG's (ROG.VX) drug Tamiflu are set to get a boost from British government plans to double its stockpile of antiviral medicines to fight any future flu pandemic, the Financial Times said.

Orders worth hundreds of millions of pounds to buy new drugs and face-masks to help minimise the impact of a pandemic will be announced by the government on Thursday, the paper reported on its Web site.

The decision comes as part of the government's revised pandemic flu plan, which also anticipates the closure of schools during an outbreak.

(Reporting by Ben Hirschler, editing by Will Waterman)

 
A share trader is pictured behind a mock one dollar bill and a mock 500 Euro note symbolizing a consumer credit note, at the German stock exchange in Frankfurt, December 18, 2008. REUTERS/Kai Pfaffenbach
Credit headwind

News headlines speak of recovery, but financing is still a big problem in Germany. The dearth of credit to tide firms over is frustrating policymakers, who are blaming reluctant banks and there is little agreement on how best to increase lending flows.  Full Article 

Market Update

  • UKUK
  • USUS
  • Europe
  • Asia
  • UK Most Actives
Currency
US $ inGBP =0.6182
Euro inGBP =0.8604
¥en inGBP =0.0067

Most Popular on Reuters UK

  • Articles
  • Videos